mylan
Photo courtesy of Mylan
13 January 2017Americas

Mylan sued for patent infringement over Aubagio

Sanofi and Genzyme have filed a complaint against Mylan for patent infringement over the drug Aubagio (teriflunomide), a treatment for relapsing forms of multiple sclerosis.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk